In the article “Prognostic Factors in Pleural Mesothelioma Patients Receiving First-Line Chemotherapy: Establishing the PLECH Baseline Risk Score” [Oncology. 2025;103:1088–1096; https://doi.org/10.1159/000543637] by Guijosa et al., the following is being corrected.
In Table 1, the percentages for lymphocytes (>1.46 vs. ≤1.46) were inadvertently inverted. The correct values are 54.6% and 45.4%, respectively.
In addition, a citation mismatch occurred, affecting only reference 39. The correct reference 39 is:
39. Feng Y, Xiong Y, Qiao T, Li X, Jia L, Han Y. Lactate dehydrogenase A: A key player in carcinogenesis and potential target in cancer therapy. Cancer Med. 2018;7:6124–36. https://doi.org/10.1002/cam4.1820
The original article has been updated to reflect this.
